Stephen Taub Premium Biopharma Specialist Cormorant Plans New $125 Million Blank-Check Venture As Cormorant makes plans for another Special Purpose Acquisition Company, here’s how the firm’s previous SPACs have fared. Stephen Taub December 16, 2025